Clinical significance of detectable and quantifiable HCV RNA at the end of treatment with ledipasvir/sofosbuvir in GT1 patients.
Benjamin MaasoumyPeter BuggischStefan MaussKlaus H W BoekerTobias MuellerRainer GüntherTim ZimmermannMichael P MannsChristoph SarrazinDietrich HüppeHeiner WedemeyerJohannes VermehrenPublished in: Liver international : official journal of the International Association for the Study of the Liver (2018)
Detectable and even quantifiable HCV RNA results are quite frequent if highly sensitive HCV RNA assays are used. However, treatment prolongation is not indicated, as SVR rates remain high in these patients.